Logo

EMD Millipore Gets CLIA Certification for Lab

Mar 12, 2013 | staff reporter

NEW YORK (GenomeWeb News) – EMD Millipore said today that its Discovery and Development Solutions business has received CLIA certification for its contract research lab located in St. Louis.

The Billerica, Mass.-based division of Germany's Merck KGaA said that the Discovery and Development Solutions business develops and performs immunoassays on human and animal samples and offers biomarker analysis for an array of therapeutic applications including diabetes, infection, neurodegenerative disease, osteoporosis, and cancer.

Christina Shasserre, VP of discovery and development services, said in a statement that the CLIA certification is an important milestone for the firm.

Filed under

CLIA
MilliporeSigma
Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.